PPI And Food Effect Study For PF-06463922 In Healthy Volunteers

each subject will receive 4 single oral doses of 100 mg PF-06463922 (treatment A: tablets without food; treatment B: tablets with food; treatment C: tablets without food with rabeprazole; treatment D: oral solution without food). There will be at least 10 days washout period between consecutive PF-06463922 single dose.

20 mg daily tablets in the evening for 5 days and Pf-06463922 on the morning of day 6 in treatment C.